Advanced Knowledge and Skills of Originator and Biosimilar Biologics

- This course aims to provide advanced knowledge and skills for health care professionals on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.

- Biosimilars present a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.

- As awareness and use of biosimilars increases globally, this course will provide information and guidance to support the effective and safe use of biosimilars in clinical settings among health care providers.

- The course will focus on enhancing knowledge and skills to affect change in attitude and behaviour of health care providers related to biosimilars.

- The course will utilize a modular approach to provide content that is accessible and informative to all learners, including pharmacists, physicians, nurses, students and young professionals, industry, and policy-makers.

- This course may be eligible for continuing education credits through professional accreditation bodies.

- The course will also provide learners with opportunities to develop skills in each of these knowledge areas, with the overall aim of improving patient-provider communication and perceptions of biosimilar use and establishing a consistent foundation among health care providers for communicating with patients about biosimilar treatment.

- This course will build off of the material in BSS101 to provide advanced knowledge and skills related to use and implementation of biosimilar medications in clinical settings.

What you'll learn

• Improve knowledge of originator biologic and biosimilar biologic medicines
• Understand scientific and clinical evidence to support appropriate cost-effective application of biosimilars across oncology, rheumatology, gastrointestinal disease, and other medical conditions
• Address misconceptions regarding use of biosimilars
• Identify the benefits and significance of biosimilar use in clinical practice and across jurisdictions
• Discuss implications of biosimilar use for clinical practice and patient education to optimize patient care and wellness